Concert Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Lexington MA United States (2006)

Organization Overview

First Clinical Trial
2010
NCT01458769
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Concert Pharmaceuticals | Concert Pharmaceuticals, Inc.